Clinical trial
Study In People With Type 2 Diabetes
NCT00196989 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00196989 |
|---|---|
| Title | Study In People With Type 2 Diabetes |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of Oral GW677954 as a Monotherapy for 12 Weeks Duration in Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Pioglitazone, GW677954 |
| Enrollment | 448 |
| Start date | Sep 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 23, 2017 |
| Countries | Argentina, Australia, Canada, Colombia, Costa Rica, Czechia, Ecuador, Latvia, Mexico, New Zealand, Peru, Russia and 1 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: